Bioinformatics tools for drug repurposing: a tutorial using heart failure as a case study
Open Access
- 16 June 2025
- journal article
- review article
- Published by Elsevier in Journal of Molecular and Cellular Cardiology Plus
- Vol. 13, 100460
Abstract
No abstract availableKeywords
Funding Information
- Fundação para a Ciência e a Tecnologia (CEECIND/03935/2021)
This publication has 59 references indexed in Scilit:
- Clinical Update in Heart Failure with Preserved Ejection FractionCurrent Heart Failure Reports, 2024
- Corrigendum to “Sex Differences in Proteomic Correlates of Coronary Microvascular Dysfunction Among Patients with Heart Failure and Preserved Ejection Fraction”European Journal of Heart Failure, 2024
- Sex differences in proteomic correlates of coronary microvascular dysfunction among patients with heart failure and preserved ejection fractionEuropean Journal of Heart Failure, 2022
- Sexual dimorphism in cardiac remodeling: the molecular mechanisms ruled by sex hormones in the heartJournal of Molecular Medicine, 2021
- PANTHER: Making genome‐scale phylogenetics accessible to allProtein Science, 2021
- Prevalence of Coronary Artery Disease and Coronary Microvascular Dysfunction in Patients With Heart Failure With Preserved Ejection FractionJAMA Cardiology, 2021
- Current and emerging drug targets in heart failure treatmentHeart Failure Reviews, 2021
- Microvascular and lymphatic dysfunction in HFpEF and its associated comorbiditiesBasic Research in Cardiology, 2020
- Repurposing approved drugs on the pathway to novel therapiesMedicinal Research Reviews, 2019
- The Gene Expression Omnibus Database2016